Short communication · 4 Aug 2026
Conference abstractPublished 14 Nov 2024
Soluble Epoxide Hydrolase Inhibitory Activity of Natural Isothiocyanates
Pacific University Oregon, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Soluble epoxide hydrolase (sEH) is a key enzyme involved in metabolizing endogenously derived fatty acid epoxides, such as epoxyeicosatrienoic acids (EETs) to their corresponding diols which lack the biological activities of their precursor EETs. Therefore, sEH is considered an important therapeutic target in a wide range of human cardiovascular diseases. Objectives: This study was undertaken to investigate the potential inhibitory activity of six Isothiocyanates (ITCs) towards sEH enzyme. Additionally, molecular docking simulation was applied to understand the interaction between the enzymes and the ligands tested. Methods: Rigid molecular docking was conducted using the human soluble epoxide hydrolase (sEH) crystal structure (3ANS) in Autodock Vina to estimate reversible binding energies of the ITCs. The sEH inhibitory activities of the tested ITCs were tested using a fluorescence-based assay and PHOME as a substrate. The selectivity of the tested sEH inhibitors was tested by measuring the inhibitory effect on microsomal epoxide hydrolase (mEH) and Cytochrome P450 (CYP) enzymes using human liver microsomes. Results: Docking resulted in binding poses that suggest the ITCs may be acting by irreversible antagonism. Sulforaphane and phenyl isothiocyanate displayed the strongest sEH inhibitory activity with IC50 values < 10 µM. None of the tested ITC exhibited a significant inhibition of mEH enzyme compared to valpromide, a positive control inhibitor. Allyl and benzyl isothiocyanate appeared to significantly inhibit CYP2D6, whereas only allyl isothiocyanate inhibited the other enzymes. The other ITCs also appeared to lower CYP activity, however their difference was not found to be statistically significant compared to no inhibitor controls. Conclusion: These findings indicate that natural ITCs demonstrate promising sEH inhibitory activities, likely by an irreversible mechanism. However, the selectivity of the smaller ITCs, especially against CYP enzymes, may need to be improved to avoid clinically-significant drug interactions.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical and Experimental Cardiology.
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Kaylen So”
- BylineArticles whose byline prints “Baily Yee”
- BylineArticles whose byline prints “Michael Espiritu”
- BylineArticles whose byline prints “Jonathan Taylor”
- BylineArticles whose byline prints “Fawzy Elbarbry”
